Who
Tina Amber St Leger
Chief Hr Officer
Company insider
Files Form 4 as: Chief Hr Officer, Immunocore Holdings.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $651K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jan 2024
- Last trade
- 18 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $32K1,000 at $32.35 | filing |
| 18 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $32K1,000 at $32.35 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | —2,119 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,119 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,119 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | —2,119 at $0.00 | filing |
| 17 Feb 2025filed 19 Feb 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,212 at $0.00 | filing |
| 17 Feb 2025filed 19 Feb 2025 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,476 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,375 at $0.00 | filing |
| 1 Apr 2024filed 3 Apr 2024 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $131K4,375 at $29.87 | filing |
| 1 Apr 2024filed 3 Apr 2024 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $280K4,375 at $64.06 | filing |
| 16 Feb 2024filed 21 Feb 2024 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,162 at $0.00 | filing |
| 3 Jan 2024filed 5 Jan 2024 | IMCR Immunocore Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,375 at $0.00 | filing |
| 3 Jan 2024filed 5 Jan 2024 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Code M | $131K4,375 at $29.87 | filing |
| 3 Jan 2024filed 5 Jan 2024 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $284K4,068 at $69.85 | filing |
| 3 Jan 2024filed 5 Jan 2024 | IMCR Immunocore HoldingsBiotechnology | SEC FORM 4 Sold | $22K307 at $70.46 | filing |
News
Immunocore (NASDAQ:IMCR) Shares Up 8% – Here's WhyIMCR · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name Tina Amber St Leger; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.